Cannabinoid-2 receptor activation protects against infarct and ischemia-reperfusion heart injury

Journal of Cardiovascular Pharmacology

Volumn 59, Issue 4, 2012, Pages 301-307

  Wang, Peng Fei ^a   Jiang, Li Sheng ^a   Bu, Jun ^a   Huang, Xiao Jin ^a   Song, Wei ^a   Du, Yong Ping ^a   He, Ben ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

acute myocardial infarction; endocannabinoid; inflammatory response; ischemia reperfusion injury; oxidative stress

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 4 [4 (1,1 DIMETHYLHEPTYL) 2,6 DIMETHOXYPHENYL] 6,6 DIMETHYLBICYCLO[3.1.1]HEPT 2 EN 2 YLMETHANOL; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; ENDOCANNABINOID; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIAL ARTERY; REPERFUSION INJURY; UPREGULATION;

ANIMALS; ARACHIDONIC ACIDS; CANNABINOIDS; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY VESSELS; DISEASE MODELS, ANIMAL; ENDOCANNABINOIDS; GLYCERIDES; HUMANS; INDOLES; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RADIAL ARTERY; REACTIVE OXYGEN SPECIES; RECEPTOR, CANNABINOID, CB2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84859903760     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3182418997     Document Type: Article

References (33)

1. Fuster V, Fayad ZA, Badimon JJ. Acute coronary syndromes: biology. Lancet. 1999;353(Suppl. 2):SII5-SII9.
2. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002;53:31-47. (Pubitemid 34020764)
3. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357:1121-1135.
4. Wagner JA, Varga K, Ellis EF, et al. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature. 1997;390:518-521. (Pubitemid 28013133)
5. Varga K, Wagner JA, Bridgen DT, et al. Platelet- and macrophagederived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J. 1998;12:1035-1044. (Pubitemid 28359585)
6. Wagner JA, Hu K, Bauersachs J, et al. Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. J Am Coll Cardiol. 2001;38:2048-2054. (Pubitemid 33116583)
7. Pacher P, Hasko G. Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning. Br J Pharmacol. 2008;153:252-262.
8. Steffens S, Veillard NR, Arnaud C, et al. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature. 2005; 434:782-786. (Pubitemid 44739523)
9. Ashton JC, Glass M. The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration. Curr Neuropharmacol. 2007; 5:73-80. (Pubitemid 47019422)
10. Mathison R, Ho W, Pittman QJ, et al. Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharidetreated rats. Br J Pharmacol. 2004;142:1247-1254. (Pubitemid 39178878)
11. Lagneux C, Lamontagne D. Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide. Br J Pharmacol. 2001;132: 793-796. (Pubitemid 32193634)
12. Joyeux M, Arnaud C, Godin-Ribuot D, et al. Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts. Cardiovasc Res. 2002;55:619-625. (Pubitemid 34874956)
13. Lepicier P, Bouchard JF, Lagneux C, et al. Endocannabinoids protect the rat isolated heart against ischaemia. Br J Pharmacol. 2003;139: 805-815. (Pubitemid 36819608)
14. Underdown NJ, Hiley CR, Ford WR. Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism. Br J Pharmacol. 2005;146:809-816. (Pubitemid 41622247)
15. Rajesh M, Mukhopadhyay P, Batkai S, et al. CB2-receptor stimulation attenuates TNF-a-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion. Am J Physiol Heart Circ Physiol. 2007;293:H2210-H2218. (Pubitemid 47605864)
16. Zhang M, Martin BR, Adler MW, et al. Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model. J Cereb Blood Flow Metab. 2007;27:1387-1396. (Pubitemid 46985356)
17. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008;29:2909-2945.
18. Gao E, Lei YH, Shang X, et al. A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ Res. 2010; 107:1445-1453.
19. Jiang LS, Pu J, Han ZH, et al. Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages. Cardiovasc Res. 2009;81:805-813.
20. Hao MX, Jiang LS, Fang NY, et al. The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages. J Lipid Res. 2010;51:2181-2190.
21. Leker RR, Gai N, Mechoulam R, et al. Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210. Stroke. 2003;34:2000-2006. (Pubitemid 36944797)
22. Batkai S, Osei-Hyiaman D, Pan H, et al. Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury. FASEB J. 2007;21:1788-1800. (Pubitemid 46855625)
23. Rajesh M, Pan H, Mukhopadhyay P, et al. Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis. J Leukoc Biol. 2007;82:1382-1389. (Pubitemid 350276948)
24. Maeda N, Osanai T, Kushibiki M, et al. Increased serum anandamide level at ruptured plaque site in patients with acute myocardial infarction. Fundam Clin Pharmacol. 2009;23:351-357.
25. Berdyshev EV, Schmid PC, Krebsbach RJ, et al. Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. FASEB J. 2001;15:2171-2178. (Pubitemid 32927934)
26. Gauthier KM, Baewer DV, Hittner S, et al. Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries. Am J Physiol Heart Circ Physiol. 2005;288:H1344-H1351. (Pubitemid 40270043)
27. Wagner JA, Abesser M, Harvey-White J, et al. 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts. J Cardiovasc Pharmacol. 2006;47:650-655. (Pubitemid 44309657)
28. Flaherty JT. Myocardial injury mediated by oxygen free radicals. Am J Med. 1991;91:79S-85S.
29. Di Filippo C, Rossi F, Rossi S, et al. Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN. J Leukoc Biol. 2004;75:453-459. (Pubitemid 38316376)
30. Montecucco F, Burger F, Mach F, et al. CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways. Am J Physiol Heart Circ Physiol. 2008; 294:H1145-H1155. (Pubitemid 351468709)
31. Montecucco F, Lenglet S, Braunersreuther V, et al. CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/ reperfusion. J Mol Cell Cardiol. 2009;46:612-620.
32. Mukhopadhyay P, Rajesh M, Pan H, et al. Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy. Free Radic Biol Med. 2010;48:457-467.
33. Parmentier-Batteur S, Jin K, Mao XO, et al. Increased severity of stroke in CB1 cannabinoid receptor knock-out mice. J Neurosci. 2002;22: 9771-9775. (Pubitemid 35332860)